Sheffield Medical Technologies Inc., Children's Hospital deal

SHM entered into an exclusive research and license option agreement with Children's Hospital to develop clotrimazole, an off-patent antifungal agent, and its metabolites and analogs, to treat diarrhea. Hospital researchers will perform preclinical studies to assess the drug's efficacy in preventing water build-up in the intestine. ...